Our Expertise
Antwerp is a uniquely integrated European hub for cell and gene therapy, covering the full value chain from research and clinical trials to GMP manufacturing, specialized logistics, and advanced hospital care. By bringing together scientific innovation, translational development, and clinical implementation within one connected ecosystem, at.las Antwerp ensures efficient bench-to-bedside translation and delivers cutting-edge cell therapies to patients.
Our Achievements and Strenghts
Leadership in ATMP clinical trials (25% of Belgium’s ATMP studies in 2023)
Antwerp leads the nation in ATMP trials, regulatory expertise, GMP process development, and clinical execution. The close connection between developers, manufacturing facilities, and treatment centers further reinforces its top position.
Belgium’s First Hospital-Based GMP Facility, evolving into a Leading Platform for Cell and Gene Therapyfor cell therapy manufacturing
The University of Antwerp (UA) and the University Hospital of Antwerp (UZA) jointly established the Centre for Cell Therapy and Regenerative Medicine (CCRG), the first hospital-based GMP facility in Belgium approved by the FAMHP. Since administering its first locally manufactured therapy in 2005, CCRG, together with its spin-off anicells, founded in 2018, has served as Belgium’s leading GMP-compliant platform for the production of cell and gene therapies.
Home to Belgium’s first collaborative ATMP ecosystem
The at.las network, founded in 2019, unites 325 Belgian members from academia, biotech, pharma, and service providers. It accelerates ATMP development through expert networking, shared knowledge, and impactful regional initiatives.
Dedicated ATMP talent development
Antwerp pioneered ATMP-focused training programs for both academic and industry needs, strengthening a future-ready workforce.
Broad and world-class expertise
Universities, research centers, hospitals, and leading companies such as J&J, Pfizer, and Galapagos drive innovation in the region, supported by strong international partnerships.